Formulation of Metformin HCl Floating Tablet using HPC, HPMC K100M, and the Combinations by Fitriani, Lili et al.
J u r n a l  S a i n s  F a r m a s i  &  K l i n i s 
(p- ISSN: 2407-7062 | e-ISSN: 2442-5435)
published by Indonesian Pharmacist Association - West Sumatra Branch
homepage: http://jsfkonline.org
ABSTRACT: Diabetes Floating tablet is one of the most suitable dosage forms that used for delivering 
long term drug release. The objective of this study was to evaluate Hydroxypropyl cellulose (HPC), 
Hydroxypropyl Methyl Cellulose (HPMC) K100M, and the combination as matrix in manufacturing 
floating tablets. Metformin HCl, an anti-diabetic, was used as a drug model. Metformin HCl floating 
tablet was manufactured by wet granulation method in three formulas using variation of matrix, which 
were 40% of HPC (F1), 40% of HPMC K100M (F2), combination of 20% HPC and 20% HPMC K100M 
(F3). Prior to tablet compaction, evaluation for granules were done which included moisture content, 
angle of repose using, bulk and tapped density, Hausner ratio, and compressibility. The evaluations 
of floating tablet were physical properties, floating ability, and in vitro drug release. The average of 
floating lag time for F1, F2, F3, were 7 minutes 13 seconds; 5 minutes 27 seconds; and 14 minutes 5 
seconds, respectively. In addition, the floating time for F1 was 3 hours 16 minutes whereas F2, F3 were 
more than 48 hours. F2 showed the best floating ability to retain the drug release, which was 84.68% 
over 8 hours, while F1 and F3 were completely dissolved less than 6 hours. 
Keywords: 
floating tablet; 
HPC; HPMC K100M; 
combination; 
metformin HCl.
*Corresponding Author: Lili Fitriani
Department of Pharmaceutics, Faculty of Pharmacy, Andalas University, 
Kampus Limau Manis, Padang, Indonesia, 25163. 
Email: fitriani.lili@gmail.com
Article History:
Received: 10 Oct 2017
Accepted: 20 Nov 2017
Published: 30 Nov 2017
Jurnal  Sa ins  Farmasi  & K l in is ,  4(2) ,  79–84
Formulation of Metformin HCl Floating Tablet using HPC, 
HPMC K100M, and the Combinations
Lili Fitriani*, Rudi Abdillah, Elfi Sahlan Ben
Department of  Pharmaceutics, Faculty of  Pharmacy, Andalas University, Indonesia
79
INTRODUCTION
Floating tablet is one drug delivery systems which 
designed to retain in stomach for a long time and release 
the active ingredient during that period [1]. Floating system 
is controlled by the low density, which is able to float and 
remain in the stomach without being influenced by the rate 
of  gastric emptying for a long period of  time [2]. The system 
is prepared by adding one or more high-concentration gel 
(20-75% b / b) gel-forming hydrocarbons in formulations 
such as sodium carboxymethyl cellulose, hydroxyethyl 
cellulose, hydroxypropyl cellulose, and hydroxypropyl 
methyl cellulose [3]. The mechanism of  the floating drug 
delivery system occurs because the bulk density of  the 
preparation is lower than that of  the stomach fluid density 
[4]. This system causes the preparation to float in the 
stomach for a certain time, without being affected by the 
time of  gastric emptying. The drug is released continuously 
from the expanding hydrophilic matrix [5,6].
Previous studies have been made on the form of  
floating tablet preparations, including the manufacture of  
floating tablet propanolol HCl using HPMC K4M, HPMC 
E15LV, HPC, carbopol, and xanthan gum as polymers, 
by direct forging method. As a result, the floating tablet 
formulated using HMPC K4M gave the best detention 
effect of  release of  the drug about 92% for 18 hours, in 
which tablets formulated with HPMC E15LV, HPC, and 
carbopol could not form a matrix. Tablets formulated 
with xanthan gum show the ability to withstand drug 
release, but have poor floating capabilities [7]. In addition, 
Sungthongjeen, et al [8] has formulated a theophylline 
floating tablet with several HPMC types, HPMC K100LV, 
HPMC K4M, and HPMC K100M by the method of  wet 
granulation, in which tablets formulated with HPMC 
K100M demonstrated the ability to withstand the best 
release of  drugs.
Based on the results of  the above research, a 
floating tablet metformin HCl was made using HPC, 
HPMC K100M, and combination of  HPC and HPMC. 
Bioavailability of  metformin HCl when administered orally 
is about 50-60%. The biological half-life of  metformin 
HCl ranges from 1.5 to 1.6 hours, and its absorption 
occurs in the proximal portion of  the small intestine [9]. 
Floating tablets of  metformin HCl are expected to float 
for a long time in the stomach fluid and the drug is in 
a soluble form where the drug is absorbed. This will 
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increase the bioavailability of  metformin HCl. Therefore, 
this dosage form is more advantageous when compared 
with conventional dosage forms. 
MATERIALS AND METHODS 
Materials
Metformin HCl was kindly donated from PT. 
Phapros, Indonesia. HPMC K100M, HPC and PVP 
K-30 were gift from PT. Kimia Farma, Indonesia. Talc, 
magnesium stearate, lactose and methanol were purchased 
from Bratachem, Indonesia. All the materials were used 
as received.  
Formulation of  tablet 
Tablets was manufactured by wet granulation method 
by varying composition, HPC HPMC, and chitosan in 
each formula as can be seen in Table 1. Granules were 
prepared by mixing Metformin HCl, HPC, HPMC, lactose 
homogenously. Then, PVP K-30 in ethanol was added as 
the binder. The wet mass mixture was dried in an oven 
at 50°C for 8 hours. The dried granules were sieved on a 
12 and 14 mesh sieve. Talc and magnesium stearate were 
added to the dried granules in a tubular mixer for 5 and 2 
minutes, consecutively.  The mass then was compacted and 
compressed to manufacture the tablets. 
Table 1. Formulation of  metformin HCl floating tablet.
Composition F1 F2 F3
Metformin HCl (mg) 500 500 500
HPC (mg) 400 - 200
HPMC K100M (mg) - 400 200
PVP K-30 (%) 5 5 5
Talc (mg) 10 10 10
Mg Stearate (mg) 10 10 10
Lactose (mg) Qs Qs Qs
Evaluation of  granules
Prior to tablet compaction, granules were evaluated 
include moisture content using a digital Infrared Moisture 
Balance, angle of  repose using a funnel, bulk and tapped 
density using a tapped density tester, Hausner ratio, and 
compressibility. 
Evaluation of  tablet
Tablets were evaluated the variety of  size and weight, 
hardness test using a Monsanto hardness tester, friability 
test using a friability tester.
Determination of  metformin HCl in tablet
An amount of  metformin HCl tablet that equivalent 
to 100 mg metformin HCl was diluted in methanol. The 
solution was sonicated and filtered using a Whatmann filter 
paper. The absorbance of  solution was measured using 
spectrophotometry UV at wavelength 237.40 nm. The 
concentration of  sample was calculated using a regression 
equation which was determined prior to the measurement. 
Determination floating lag time and floating time 
Tablet was placed in a beaker glass containing 250 mL 
of  0.1N HCl pH 1.2. The floating lag time is determined 
by the time in which the tablet arise to the surface and 
float. The duration of  the tablet floats is known as floating 
time.
Drug release study
Drug release test was performed using a dissolution 
tester using type 2 (Hanson research SR08, USA) with a 
speed of  100 rpm in 900 mL of  0.1N HCl (pH 1.2) as the 
medium. The temperature was maintained at 37±0.5 °C. 
Sample was pipetted in 5, 15, 30, 45, 60, 90, 120, 180, 240, 
300, 360, 420, and 480, minutes. Samples were analyzed 
using spectrophotometry UV as described previously in 
determination of  metformin HCl. Each formula tablet 
was done in triplicate (n = 3).
 
RESULTS AND DISCUSSION 
Granules formed from each formula were tested in 
accordance with general granule testing. The evaluations 
performed for granules were moisture content, angle 
of  repose, bulk and tapped density, Hausner ratio, 
and compressibility. The results are shown in Table 2. 
These results were compared to the requirements in the 
literature. The moisture content, angle of  repose, Hausner 
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Table 2. Evaluation of  granules.
Parameters F1 F2 F3
Moisture content (%) 4.51 ± 0.23 3.81 ± 0.13 4.35 ± 0.05 
Angle of repose (°) 22.43 ± 0.76 29.36 ± 0.39 23.76 ± 0.63
Bulk density (g/mL) 0.42 ± 0.01 0.25 ± 0.01 0.36 ± 0.02
Tapped density (g/mL) 0.49 ± 0.01 0.28 ± 0.01 0.41± 0.01
Hausner ratio 1.16 ± 0.01 1.13 ± 0.01 1.15 ± 0.02
Compressibility (%) 16.49 ± 0.31 12.66 ± 1.17 15.06 ± 2.24
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ratio and compressibility in all granules formula met the 
requirement.
The granules were then mixed with talc and magnesium 
stearate to be compacted into tablets. Furthermore the 
tablets were evaluated the quality which include weight 
uniformity, size uniformity, hardness test, friability test, 
and drug assay The result of  tablet evaluations can be seen 
in Table 3. The result of  average weight, size and diameter 
met the requirement of  Indonesia Pharmacopea III [10]. 
In general, the criteria for good tablet hardness was 4-8 kg 
/cm2. From the results of  hardness test can be seen that 
tablets using HPC as a polymer in the formula had the 
value above the criteria of  a good tablet hardness. It can be 
caused by the nature of  HPC. The friability of  tablet also 
met the requirement which is less than 0.8%. Moreover, 
the metformin HCl assay in tablets met the requirement, 
which the drug content is in a range 90 – 110 %.
The floating tablet of  metformin HCl is shown in 
Figure 1 and result of  floating lag time and floating time of  
each formula can be seen in Table 4. The main requirement 
for preparation can float is the system must continue 
to have a specific gravity lower than the overall specific 
gravity of  the specific contents of  the stomach [11]. When 
the density of  tablets was less than 1, the tablet becomes 
floating [7]. Differences floating lag time can be influenced 
by the molecular weight of  each polymer. The smaller the 
value of  the molecular weight of  a polymer, the faster the 
tablet floats to the surface of  the medium. Floating time 
is also affected by the solubility of  the polymer used as a 
matrix. The longer the matrix is dissolved in the medium, 
the longer the matrix floats on the surface of  the medium 
[12].
The result of  dissolution test of  metformin HCl 
tablet can be seen in Figure 2. From these results it can be 
seen that the only formula 2, which uses a single K100M 
HPMC as the polymer, which can withstand the release 
of  the drug, while the other formulas, the drug has been 
off  entirely before 480 minutes. This happens because the 
HPMC K100M forming a barrier gel with high viscosity, 
which is more resistant to the diffusion process, so that the 
drug release from the matrix tablets to be slow [8]. Tablets 
are formulated with HPC cannot resist the drug release. 
HPC is easily soluble in water temperatures below 38 °C, 
in hot water, insoluble and precipitates form a precipitate 
which expands at a temperature between 40-45 °C. HPC 
probably could not resist the drug release in dissolution 
conditions used [7]. The polymers used in the formulation 
of  a floating tablet dosage form should be able to form 
a barrier gel that is cohesive and should dissolve slowly, 
as an appropriate drug reservoir [13]. F3, which used a 
Table 3. Tablet evaluations
Evaluations
Formula
F1 F2 F3
Average weight (mg) 502.7 ± 2.02 498.1 ± 1.91 498.7 ± 1.17
Average diameter (mm) 13 ± 00 13 ± 00 13 ± 00
Hardness (kg/cm2) 18.4 ± 0.52 4.4 ± 0.52 16.1 ± 0.57
Friability (%) 0.03 0.32 0.06
Drug content (%) 96.86 96.51 98.92
Figure 1. Floating tablet of  Metformin HCl (a) F1, (b) F2 and (c) F3
Table 4. Floating lag time and floating time.
Formula Floating lag time (minutes) Floating time (hours)
F1 07.13 03.16
F2 05.27 >48
F3 14.05 >48
combination of  HPC and HPMC K100M as polymers, 
dissolved completely in 365 minutes. This can be caused 
by barrier gel that forms a lower viscosity when compared 
with formula 2, which used HPMC as the polymer. The 
decrease viscosity gel barrier due to reduced concentration 
of  HPMC K100M were used, while the HPC does not 
form a gel barrier due to the acidic pH, HPC undergo 
hydrolysis which results in HPC solution viscosity [13,14]. 
This will cause erosion and dilution of  the matrix tablet 
[15].
CONCLUSION
Based on the data in the research, it can be concluded that 
metformin HCl floating tablet used HPMC (F2) was the 
best formula, as the matrix can withstand drug release up 
to 8 hours.
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Figure 2. Dissolution profile of  metformin HCl floating tablets. 
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